TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

ROSEN, THE FIRST FILING FIRM, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Rosen Law Firm
ROSEN, THE FIRST FILING FIRM, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX

Rosen Law Firm filed a class action lawsuit against Telix Pharmaceuticals for allegedly making false statements about prostate cancer therapeutic candidates and supply chain quality during February 21-August 28, 2025.

Insights
BACpO   negative

Buffett sold 41% of Berkshire's stake due to potential interest rate sensitivity, high valuation premium, and potential future tax considerations


TLX   negative

Lawsuit alleges company made materially false and misleading statements about its prostate cancer therapeutic progress and supply chain quality, suggesting potential corporate misrepresentation